CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 6, 2024 · earnings

KROS earnings: a positive outcome, +6.2%

On November 6, 2024, Keros Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +6.2% in the window around the event.

The move

$62.58
1d before
$66.45
Event day
$67.17
1d after
$68.15
5d after

Pre-catalyst setup

-0.3%
30-day run-up
3347%
30-day volatility
1.0×
volume spike